Condition
Stage IV Bladder Urothelial Carcinoma AJCC v7 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Stage IV Bladder Urothelial Carcinoma AJCC v7 clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Canada (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using blood tests to guide immunotherapy after bladder cancer surgery
This study is testing if blood tests can help doctors find out which bladder cancer patients need extra treatment after surgery and if combining two immunotherapy drugs works better than just one.
-
Collecting blood and tissue samples from patients with recurrent or metastatic prostate or bladder cancer
This study is collecting blood and tissue samples from patients with recurrent or advanced prostate or bladder cancer to see if they can find new ways to improve treatment and understand why some treatments don’t work.
Related topics
Quick answers
How many Stage IV Bladder Urothelial Carcinoma AJCC v7 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.